TransThoracic Ultrasound for Descending Aortic Aneurysms

by palligoelme@gmail.com | Aug 7, 2026 | Clinical Trials

​ Conditions: Descending Aortic Aneurysm; Ultrasound; Accuracy; Feasibility; Reproducibility Sponsors: Imperial College London Not yet recruiting Conditions: Descending Aortic Aneurysm; Ultrasound; Accuracy; Feasibility; Reproducibility Sponsors: Imperial College...

Graftless Lateral Sinus Lifting Using Peizo Electric Device in Patients With Atrophic Maxilla

by palligoelme@gmail.com | Aug 7, 2026 | Clinical Trials

​ Conditions: Sinus Lifting Interventions: Procedure: lateral sinus lifting with guide; Procedure: conventional lateral sinus lifting Sponsors: Alexandria University Completed Conditions: Sinus Lifting Interventions: Procedure: lateral sinus lifting with guide;...

Occupational Therapy Approach in ARX-Related Epilepsy

by palligoelme@gmail.com | Aug 7, 2026 | Clinical Trials

​ Conditions: Drug-Resistant Epilepsy; ARX-Related Epilepsy Interventions: Behavioral: Occupational Therapy; Other: Medikal Ketogenic Diet Therapy Sponsors: Uskudar University Completed Conditions: Drug-Resistant Epilepsy; ARX-Related Epilepsy Interventions:...

Evaluation of the Effects of Colipral on Microbiota Gut Composition in Patients Presenting With Ulcerative Colitis During Remission Phase and Functional Disorders

by palligoelme@gmail.com | Aug 7, 2026 | Clinical Trials

​ Conditions: Inflammatory Bowel Disease, Ulcerative Colitis Type; Functional Disorder of Gastrointestinal Tract Interventions: Dietary Supplement: Food Supplement Colipral in film-coated tablets containing Escherichia coli 5C LMG S-33222; Other: Placebo Sponsors:...

Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)

by palligoelme@gmail.com | Aug 7, 2026 | Clinical Trials

​ Conditions: Thyroid Eye Disease, TED; Graves Orbitopathy Interventions: Drug: linsitinib; Drug: Placebo Sponsors: Sling Therapeutics, Inc. Recruiting Conditions: Thyroid Eye Disease, TED; Graves Orbitopathy Interventions: Drug: linsitinib; Drug: Placebo Sponsors:...